ATE360641T1 - Peptide aus t-zellepitopen - Google Patents

Peptide aus t-zellepitopen

Info

Publication number: ATE360641T1
Authority: AT; Austria
Prior art keywords: japanese cypress; pollen; peptides; cell epitopes; peptide
Prior art date: 1996-06-14

Application number

AT97927371T

Other languages

English (en)

Inventor

Kohsuke Kino

Kazuo Dairiki

Original Assignee

Meiji Dairies Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-14

Filing date

1997-06-12

Publication date

2007-05-15

1997-06-12 Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp

2007-05-15 Application granted granted Critical

2007-05-15 Publication of ATE360641T1 publication Critical patent/ATE360641T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Botany (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Ophthalmology & Optometry (AREA)
Otolaryngology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AT97927371T 1996-06-14 1997-06-12 Peptide aus t-zellepitopen ATE360641T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP15352796		1996-06-14

Publications (1)

Publication Number	Publication Date
ATE360641T1 true ATE360641T1 (de)	2007-05-15

Family

ID=15564483

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97927371T ATE360641T1 (de)	1996-06-14	1997-06-12	Peptide aus t-zellepitopen

Country Status (8)

Country	Link
US (3)	US7112329B1 (de)
EP (1)	EP0960887B1 (de)
JP (2)	JP3734040B2 (de)
CN (3)	CN101307095A (de)
AT (1)	ATE360641T1 (de)
CA (1)	CA2258125C (de)
DE (1)	DE69737659T2 (de)
WO (1)	WO1997047648A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2258125C (en) *	1996-06-14	2010-11-23	Meiji Milk Products Co., Ltd.	T-cell epitope peptides
WO2010128364A1 (en) *	2009-05-04	2010-11-11	Stallergenes S.A.	Method for the prevention or treatment of taxodiaceae pollen allergy
EP2577308A4 (de) *	2010-06-03	2013-12-04	Phadia Ab	Verfahren zur entscheidungsunterstützung bei einer allergiediagnose
KR102386481B1 (ko)	2012-06-15	2022-04-14	이뮤노믹 쎄라퓨틱스, 인크.	알레르기 치료용 핵산
WO2014017599A1 (ja) *	2012-07-26	2014-01-30	大鵬薬品工業株式会社	新規ヒノキ花粉アレルゲンのｔ細胞エピトープペプチド
US9359262B2 (en)	2012-08-30	2016-06-07	Corning Incorporated	Compositions and methods for plugging honeycomb bodies with reduced plug depth variability
US8999484B2 (en)	2012-08-30	2015-04-07	Corning Incorporated	Compositions and methods for plugging honeycomb bodies with reduced plug depth variability
WO2016209959A2 (en)	2015-06-22	2016-12-29	Alk-Abelló A/S	Peptide combinations and use thereof in treating cedar pollen allergy
GB201601872D0 (en) *	2016-02-02	2016-03-16	Circassia Ltd	Japanese cedar and japanese cypress peptides for preventing or treating allergy
FR3064482B1 (fr) *	2017-04-03	2020-11-13	Horus Pharma	Composition topique de doxycycline
SG11201911430PA (en)	2017-07-04	2020-01-30	Curevac Ag	Novel nucleic acid molecules
SG11202002186VA (en)	2017-10-19	2020-05-28	Curevac Ag	Novel artificial nucleic acid molecules
TW202039534A (zh)	2018-12-14	2020-11-01	美商美國禮來大藥廠	KRAS變體mRNA分子
WO2025088088A1 (en)	2023-10-27	2025-05-01	CureVac SE	Rna composition for improving cell therapy

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4630466A (en)	1983-10-08	1986-12-23	Hauni-Werke Korber & Co. Kg.	Apparatus for testing rod-shaped articles of the tobacco processing industry
JP2900571B2 (ja)	1990-02-07	1999-06-02	味の素株式会社	スギ花粉症治療剤
JPH0725794B2 (ja)	1990-03-23	1995-03-22	呉羽化学工業株式会社	新規なペプチド
ATE160818T1 (de)	1990-06-01	1997-12-15	Chiron Corp	Zusammensetzungen und verfahren zur identifizierung von molekülen mit biologischer wirksamkeit
US5650489A (en)	1990-07-02	1997-07-22	The Arizona Board Of Regents	Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
WO1994001560A1 (en) *	1991-07-12	1994-01-20	Immulogic Pharmaceutical Corporation	Allergenic proteins and peptides from japanese cedar pollen
AU2300492A (en)	1991-07-12	1993-02-11	Immulogic Pharmaceutical Corporation	Allergenic proteins and peptides from japanese cedar pollen
ATE382699T1 (de)	1991-10-16	2008-01-15	Merck Patent Gmbh	Verfahren zum entwurf von rekombitopen peptiden
IL105153A (en)	1992-03-25	1999-12-22	Immulogic Pharma Corp	Therapeutic compositions comprising peptides derived from human t cell reactive feline protein
NZ246806A (en) *	1992-09-01	1996-09-25	Immulogic Pharma Corp	Allergenic proteins and peptides from japanese cedar pollen, recombinant production and compositions
US5317028A (en)	1992-09-08	1994-05-31	Warner-Lambert Co.	7-((substituted)amino)-8((substituted)carbonyl)-methylamino-1-oxaspiro(4,5)decanes useful in Parkinson's disease, dystonia, and other movement disorders
EP0669983A1 (de) *	1992-11-12	1995-09-06	Immulogic Pharmaceutical Corporation	Allergene proteine und peptide von pollen der japanischen zeder
WO1995002412A1 (fr) *	1993-07-16	1995-01-26	Meiji Milk Products Co., Ltd.	Agent antiallergie
JP3474898B2 (ja)	1993-10-20	2003-12-08	明治乳業株式会社	スギ花粉アレルゲンのｔ細胞エピトープペプチド及びそのアナログペプチド
DE69418433T2 (de)	1993-11-05	1999-10-28	Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama	Allergenisches Polypeptid von japanischen Zederpollen und diese kodierende DNA
JP3649460B2 (ja)	1993-11-05	2005-05-18	明治乳業株式会社	スギ花粉アレルゲンＣｒｙｊＩＩエピトープ
WO1995027786A1 (en)	1994-04-08	1995-10-19	Immulogic Pharmaceutical Corporation	Pharmaceutical formulations for treating japanese cedar pollen allergy
JP3588166B2 (ja)	1994-09-10	2004-11-10	株式会社林原生物化学研究所	ペプチドとその用途
JP3707817B2 (ja) *	1994-12-21	2005-10-19	明治乳業株式会社	ヒノキ花粉アレルゲン
JP3734855B2 (ja)	1995-04-07	2006-01-11	株式会社林原生物化学研究所	ペプチド及びその用途
EP0923940B1 (de)	1996-03-10	2008-09-03	Meiji Dairies Corporation	Auf peptiden basierendes immunotherapeutisches mittel gegen allergien
CA2258125C (en) *	1996-06-14	2010-11-23	Meiji Milk Products Co., Ltd.	T-cell epitope peptides
JP4474512B2 (ja)	2003-06-27	2010-06-09	財団法人浜松科学技術研究振興会	ヘリセン系化合物及びその製造方法

1997
- 1997-06-12 CA CA2258125A patent/CA2258125C/en not_active Expired - Fee Related
- 1997-06-12 AT AT97927371T patent/ATE360641T1/de not_active IP Right Cessation
- 1997-06-12 CN CNA2008100022202A patent/CN101307095A/zh active Pending
- 1997-06-12 EP EP97927371A patent/EP0960887B1/de not_active Expired - Lifetime
- 1997-06-12 DE DE69737659T patent/DE69737659T2/de not_active Expired - Lifetime
- 1997-06-12 CN CN97197087A patent/CN1227566A/zh active Pending
- 1997-06-12 JP JP50144798A patent/JP3734040B2/ja not_active Expired - Fee Related
- 1997-06-12 CN CN2011101903100A patent/CN102286077A/zh active Pending
- 1997-06-12 WO PCT/JP1997/002031 patent/WO1997047648A1/ja active IP Right Grant
- 1997-06-12 US US09/202,464 patent/US7112329B1/en not_active Expired - Fee Related
2006
- 2006-02-14 US US11/354,543 patent/US7407657B2/en not_active Expired - Fee Related
2008
- 2008-02-14 JP JP2008032516A patent/JP4176821B2/ja not_active Expired - Fee Related
- 2008-06-27 US US12/163,896 patent/US7547440B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69737659T2 (de)	2007-12-27
JP3734040B2 (ja)	2006-01-11
EP0960887A4 (de)	2002-09-18
US7112329B1 (en)	2006-09-26
US20060188446A1 (en)	2006-08-24
US7547440B2 (en)	2009-06-16
EP0960887B1 (de)	2007-04-25
CN1227566A (zh)	1999-09-01
US20080274972A1 (en)	2008-11-06
WO1997047648A1 (en)	1997-12-18
CA2258125A1 (en)	1997-12-18
JP4176821B2 (ja)	2008-11-05
EP0960887A1 (de)	1999-12-01
JP2008195718A (ja)	2008-08-28
CN101307095A (zh)	2008-11-19
CA2258125C (en)	2010-11-23
US7407657B2 (en)	2008-08-05
DE69737659D1 (de)	2007-06-06
CN102286077A (zh)	2011-12-21

Publication	Publication Date	Title
ATE360641T1 (de)	2007-05-15	Peptide aus t-zellepitopen
EP0548200A4 (de)	1994-04-06
ID28299A (id)	2001-05-10	Protein-protein reseptor seperti toll manusia metoda-metoda dan reagen-reagen yang berhubungan
DE69636938D1 (de)	2007-04-12	HYBRID AUS INTERFERON-alpha UND IMMUNGLOBULIN Fc-FRAGMENT VERBUNDEN DURCH EIN NICHT IMMUNOGENES PEPTID
HUT71211A (en)	1995-11-28	T cell epitopes of the major allergens from dermatophagoides (house dust mite)
ZA924271B (en)	1993-12-13	Tri-and tetravalent mono specific antigen binding proteins
EP1332158A2 (de)	2003-08-06	Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE59309458D1 (de)	1999-04-22	Synthetische Peptide, Antikörper dagegen und ihre Verwendung
FI954269A7 (fi)	1995-09-12	Raiheinäsiitepölyallergeenin T-soluepitoopit
WO1999003987A3 (fr)	1999-04-08	Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
ATE248190T1 (de)	2003-09-15	Chemoattraktion-auslösender faktor aus lymphozyten und dessen verwendungen
DE69638024D1 (de)	2009-10-22	Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
DK0610335T3 (da)	2008-04-28	Fremgangsmåder til udformning af rekombitope peptider
DE69820449D1 (de)	2004-01-22	T-zell-membranprotein (tirc7), davon abgeleitete peptide und antikörper und ihre verwendungen
FI960629A7 (fi)	1996-04-12	Raiheinäsiitepöly allergeenin T-soluepitoopit
ATE289612T1 (de)	2005-03-15	Diagnostische verwendungen von gegen acetylcholinesterase oder deren c-terminale peptide gerichteten antikörpern
EP0876397A4 (de)	1999-08-18	Durch hla-b44 moleküle präsentierte tumor-abstossungsantigene und ihre verwendungen
DE69928925D1 (de)	2006-01-19	Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
NO950526L (no)	1995-04-11	T-celleepitoper av raigresspollen-allergen
ATE207935T1 (de)	2001-11-15	Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
ATE502046T1 (de)	2011-04-15	T-zellen-epitope des cyn-d-1-allergens aus bermudagraspollen
SE9703531D0 (sv)	1997-09-30	Non-anaphlactic forms of allergens and their use
ATE462719T1 (de)	2010-04-15	Hausstaubmilbenallergen
van Milligen et al.	1994	IgE and lgG4 Binding to Synthetic Peptides of the Cat (Felis domesticus) Major Allergen Fel d I
RU95116353A (ru)	1997-08-20	Способ получения нонапептидэтиламида

Legal Events

Date	Code	Title	Description
2007-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties